• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

老年人药物处置的改变:关注老年综合征。

Alterations in drug disposition in older adults: a focus on geriatric syndromes.

机构信息

Health and Biomedical Innovation, UniSA: Clinical and Health Sciences, University of South Australia , Adelaide, Australia.

Quality Use of Medicines and Pharmacy Research Centre, UniSA: Clinical and Health Sciences, University of South Australia , Australia.

出版信息

Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):41-52. doi: 10.1080/17425255.2021.1839413. Epub 2020 Nov 2.

DOI:10.1080/17425255.2021.1839413
PMID:33078628
Abstract

INTRODUCTION

Age-associated physiological changes can alter the disposition of drugs, however, pathophysiological changes associated with geriatric syndromes in older adults may lead to even greater heterogeneity in pharmacokinetics. Geriatric syndromes are common health problems in older adults which have multifactorial causes and do not fit into distinct organ-based disease categories. With older adults being the greatest users of medications, understanding both age- and geriatric syndrome-related changes is important clinically to ensure safe and effective medication use.

AREAS COVERED

This review provides an overview of current evidence regarding pharmacokinetic alterations that occur with aging and in common geriatric syndromes, including frailty, sarcopenia, dementia, polypharmacy and enteral feeding. The evidence is presented according to the four primary pharmacokinetic processes (Absorption, Distribution, Metabolism and Excretion).

EXPERT OPINION

There is some evidence to inform our understanding of the impact of chronological aging and various geriatric syndromes on drug disposition. However, many areas require more research, including drug induced inhibition and induction of cytochrome P450 enzymes and the clinical utility of emerging methods for estimating renal function. There is a need to develop tools to predict alterations in drug disposition in subgroups of older adults, particularly where the currently available clinical information is sparse.

摘要

简介

与年龄相关的生理变化会改变药物的分布,但与老年人老年综合征相关的病理生理变化可能导致药代动力学的更大异质性。老年综合征是老年人常见的健康问题,其病因复杂,不符合特定的器官疾病类别。由于老年人是最大的药物使用者,因此了解与年龄和老年综合征相关的变化在临床上对于确保安全有效的药物使用非常重要。

涵盖领域

本综述概述了与衰老和常见老年综合征(包括虚弱、肌少症、痴呆、多种药物治疗和肠内喂养)相关的药代动力学改变的现有证据。证据根据四个主要的药代动力学过程(吸收、分布、代谢和排泄)呈现。

专家意见

有一些证据可以帮助我们了解生理年龄和各种老年综合征对药物处置的影响。然而,许多领域需要更多的研究,包括药物诱导的细胞色素 P450 酶抑制和诱导,以及评估肾功能的新兴方法的临床实用性。需要开发工具来预测老年人群亚组中药物处置的改变,特别是在当前临床信息稀缺的情况下。

相似文献

1
Alterations in drug disposition in older adults: a focus on geriatric syndromes.老年人药物处置的改变:关注老年综合征。
Expert Opin Drug Metab Toxicol. 2021 Jan;17(1):41-52. doi: 10.1080/17425255.2021.1839413. Epub 2020 Nov 2.
2
Alterations in drug disposition in older adults.老年人药物处置的改变。
Expert Opin Drug Metab Toxicol. 2015 Apr;11(4):491-508. doi: 10.1517/17425255.2015.1004310. Epub 2015 Jan 19.
3
Pharmacokinetic and pharmacodynamic alterations in older people with dementia.老年人痴呆症患者的药代动力学和药效学改变。
Expert Opin Drug Metab Toxicol. 2017 Jun;13(6):651-668. doi: 10.1080/17425255.2017.1325873. Epub 2017 May 10.
4
Pharmacokinetic considerations in chronic kidney disease and patients requiring dialysis.慢性肾脏病及需要透析的患者的药代动力学考量
Expert Opin Drug Metab Toxicol. 2014 Aug;10(8):1131-43. doi: 10.1517/17425255.2014.931371. Epub 2014 Jun 24.
5
Pharmacokinetic and pharmacodynamic alterations in the geriatric patient.老年患者的药代动力学和药效学改变。
Consult Pharm. 2008 Apr;23(4):324-34. doi: 10.4140/tcp.n.2008.324.
6
Polypharmacy in older adults: Association Rule and Frequent-Set Analysis to evaluate concomitant medication use.老年人的多重用药:使用关联规则和频繁集分析来评估合并用药情况。
Pharmacol Res. 2017 Feb;116:39-44. doi: 10.1016/j.phrs.2016.12.018. Epub 2016 Dec 14.
7
Pharmacotherapeutics in older adults.老年人的药物治疗学
J Wound Ostomy Continence Nurs. 2006 Nov-Dec;33(6):630-6; quiz 637-8. doi: 10.1097/00152192-200611000-00007.
8
Medication-related harm: a geriatric syndrome.药物相关伤害:一种老年综合征。
Age Ageing. 2019 Dec 1;49(1):7-11. doi: 10.1093/ageing/afz121.
9
An update on the clinical consequences of polypharmacy in older adults: a narrative review.老年人多种药物治疗的临床后果更新:叙述性评论。
Expert Opin Drug Saf. 2018 Dec;17(12):1185-1196. doi: 10.1080/14740338.2018.1546841. Epub 2018 Dec 12.
10
Medication use in older patients and age-blind approach: narrative literature review (insufficient evidence on the efficacy and safety of drugs in older age, frequent use of PIMs and polypharmacy, and underuse of highly beneficial nonpharmacological strategies).老年患者的药物使用与年龄盲视方法:叙述性文献综述(关于老年人药物疗效和安全性的证据不足、不适当药物频繁使用和多重用药以及有益非药物策略使用不足)
Eur J Clin Pharmacol. 2019 Apr;75(4):451-466. doi: 10.1007/s00228-018-2603-5. Epub 2019 Jan 4.

引用本文的文献

1
Unveiling Drug-Drug Interactions in Dental Patients: A Retrospective Real-World Study.揭示牙科患者中的药物相互作用:一项回顾性真实世界研究。
Dent J (Basel). 2025 Jun 9;13(6):255. doi: 10.3390/dj13060255.
2
Office and home blood pressure and their difference according to frailty status among community-dwelling older adults: the NOSE study.社区居住老年人中根据虚弱状态划分的诊室血压、家庭血压及其差异:鼻腔研究
Hypertens Res. 2025 Apr;48(4):1389-1398. doi: 10.1038/s41440-025-02145-8. Epub 2025 Feb 14.
3
Adverse event profile of memantine and donepezil combination therapy: a real-world pharmacovigilance analysis based on FDA adverse event reporting system (FAERS) data from 2004 to 2023.
美金刚与多奈哌齐联合治疗的不良事件概况:基于2004年至2023年美国食品药品监督管理局不良事件报告系统(FAERS)数据的真实世界药物警戒分析
Front Pharmacol. 2024 Jul 17;15:1439115. doi: 10.3389/fphar.2024.1439115. eCollection 2024.
4
Navigating Drug-Drug Interactions in Multimorbid Patients: Utilizing Tools, Guidelines, and Clinical Implications.多病症患者中药物相互作用的应对:利用工具、指南及临床意义
Curr Drug Saf. 2025;20(3):247-252. doi: 10.2174/0115748863312192240721192921.
5
An update on drug-drug interactions in older adults living with human immunodeficiency virus (HIV).老年人类免疫缺陷病毒(HIV)感染者药物-药物相互作用的最新研究进展。
Expert Rev Clin Pharmacol. 2024 Jul;17(7):589-614. doi: 10.1080/17512433.2024.2350968. Epub 2024 Jun 30.
6
Evaluating Demographic Representation in Clinical Trials: Use of the Adaptive Coronavirus Disease 2019 Treatment Trial (ACTT) as a Test Case.评估临床试验中的人口统计学代表性:以2019年适应性冠状病毒病治疗试验(ACTT)为例
Open Forum Infect Dis. 2023 May 27;10(6):ofad290. doi: 10.1093/ofid/ofad290. eCollection 2023 Jun.
7
Polypharmacy with potentially inappropriate medications as a risk factor of new onset sarcopenia among community-dwelling Japanese older adults: a 9-year Kashiwa cohort study.药物治疗方案繁杂且存在潜在不适当用药与社区居住的日本老年人群肌少症新发病例的风险因素有关:柏市队列研究 9 年随访结果
BMC Geriatr. 2023 Jun 26;23(1):390. doi: 10.1186/s12877-023-04012-y.
8
Critical Issues in the Management of Agitation, Aggression, and End-of-Life in Delusional Disorder: A Mini-Review.妄想障碍中激越、攻击行为及临终管理的关键问题:一项小型综述
Healthcare (Basel). 2023 Feb 5;11(4):458. doi: 10.3390/healthcare11040458.
9
Sarcopenia is associated with a greater risk of polypharmacy and number of medications: a systematic review and meta-analysis.肌少症与多药治疗和用药数量的风险增加有关:系统评价和荟萃分析。
J Cachexia Sarcopenia Muscle. 2023 Apr;14(2):671-683. doi: 10.1002/jcsm.13190. Epub 2023 Feb 13.
10
Willingness of older people living with dementia and mild cognitive impairment and their caregivers to have medications deprescribed.患有痴呆症和轻度认知障碍的老年人及其护理人员愿意减少药物剂量。
Age Ageing. 2023 Jan 8;52(1). doi: 10.1093/ageing/afac335.